Clinical Trials Directory

Trials / Terminated

TerminatedNCT03568253

Longitudinal Follow-up of High Viscosity Glassionomer IonoStar Plus Versus a Composite Bulk X-tra-Fil Combined With Futurabond U (Splith Mouth Study): Reunion Island, Circus of Mafate

Longitudinal Follow-up of High Viscosity Glassionomer IonoStar Plus Versus a Composite Bulk X-tra-Fil Combined With Futurabond U (Splith Mouth Study)

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
65 (actual)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The main objective is the longitudinal follow-up and comparison of the maintenance of the dental filling materials up to 24 months using the HVGIC IonoStar Plus versus Bulk X-Tra -Fil composite (Futurabond U adhesive system). 150 patients will be recruited in the Mafate dental health center. Patients with minimum 2 carious lesions (or multiple of 2, maximum 6) class I or II moderate not including the cusps, and touching the outside part of the middle of dentin. Assignment period will be 4 years: Inclusion period 18 months with 2 years following (6-month, 1 year and 2 years checking) and 3 months for statistical analysis and publications process Estimation of the parameters associated with a failure of the restoration at 24 months will follow the FDI scores. The Secondary objectives are to evaluate the caries risk of isolated population thanks to Cambra application and estimate the concordance of the judgment of maintaining the restoration between the expert in-situ and experts based on the images remotely.

Conditions

Interventions

TypeNameDescription
OTHERCaries treatmentTreatment by Bulk fil composite after randomization of the tooth
OTHERCaries treatmentTreatment by High viscosity glass ionomer after randomization of the tooth

Timeline

Start date
2018-09-21
Primary completion
2023-05-20
Completion
2023-05-20
First posted
2018-06-26
Last updated
2024-08-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03568253. Inclusion in this directory is not an endorsement.